Global Hemodynamic Monitoring Devices Market: Focus on Product, Modality, Setting, and 21 Countries – Analysis and Forecast, 2021-2030

Table of Contents

Executive Summary 1 Product Definition 2 Scope of Research 2.1 Scope of Study 2.2 Inclusion and Exclusion Criteria 2.3 Key Questions to be Answered in the Report 3 Research Methodology 3.1 Data Collection and Analysis 3.2 Data Sources 3.2.1 Primary Data Sources 3.2.2 Secondary Data Sources 3.3 Data Triangulation 3.4 Market Estimation 3.5 Forecast Period Selection Criteria 3.6 Assumptions and Limitations 4 Impact of COVID-19 on Hemodynamic Monitoring Devices 4.1 Impact on Facilities 4.2 Impact on Remote Monitoring 4.3 Impact on Market Size 4.3.1 Scenario Comparative Analysis (Pre-COVID, During- COVID, Post-COVID) 4.3.2 Quarterly Regional Impact 4.3.3 Impact Due to COVID-19 4.3.3.1 Short-Term 4.3.3.2 Mid-Term 4.3.3.3 Long-Term 4.4 Future Outlook and Recommendations 5 Industry Analysis 5.1 Disease Epidemiology Analysis and Forecast (2000-2030) 5.1.1 Cardiovascular Diseases 5.1.2 Diabetes 5.2 Technology Landscape 5.2.1 Key Trends 5.2.1.1 Short-Term Potential (2-4 Years) 5.2.1.2 Mid-Term Potential (5-10 Years) 5.2.1.3 Long-Term Potential (8-12 Years) 5.3 Value Chain Analysis 5.4 End User Perceptions 5.5 Funding Scenario 5.6 Regulatory Framework and Government Initiatives 5.6.1 North America 5.6.1.1 Food and Drug Administration (FDA) 5.6.1.2 Health Canada 5.6.2 Europe 5.6.3 Asia-Pacific 5.6.3.1 Japan 5.6.3.2 China 5.6.4 Latin America 5.6.4.1 Brazil 5.6.4.2 Mexico 5.7 Patent Analysis 5.7.1 Awaited Technological Developments 5.7.2 Patent Filing Trend 5.8 Product Benchmarking 5.9 Ongoing Clinical Trials 6 Competitive Landscape 6.1 Market Share Analysis 6.2 Key Strategies and Developments 6.2.1 Regulatory and Legal 6.2.2 Funding Activities 6.2.3 Mergers & Acquisition Activities 6.2.4 Partnerships, Collaborations, and Business Expansions 6.2.5 New Offerings 6.3 Business Model Analysis 6.4 Key Players-Competitive Benchmarking 7 Global Hemodynamic Monitoring Devices Market Scenario 7.1 Assumptions and Limitations 7.2 Key Findings and Opportunity Assessment 7.3 Global Hemodynamic Monitoring Devices Market Size and Forecast 7.3.1 Realistic Growth Scenario 7.3.2 Pessimistic/Conservative Growth Scenario 7.3.3 Optimistic Growth Scenario 7.4 Market Dynamics 7.4.1 Impact Analysis 7.4.2 Market Growth Promoting Factors 7.4.2.1 Rising Prevalence of Cardiac Disorders 7.4.2.2 Increasing Technology Integration in Hemodynamic Monitoring 7.4.2.3 Development of Remote Hemodynamic Monitoring Devices 7.4.2.4 Entry of Key Medical Device Companies Through Mergers and Acquisitions 7.4.3 Market Growth Restraining Factors 7.4.3.1 Lack of Clinically Validated Evidence for Non-Invasive Hemodynamic Monitoring 7.4.3.2 Side-Effects Associated with Invasive Hemodynamic Monitoring 7.4.4 Market Growth Opportunities 7.4.4.1 The Emergence of Regional Hemodynamic Monitoring Devices Companies 7.4.4.2 Development of Patient-Friendly Hemodynamic Monitoring Systems 7.4.4.3 Development of Virtual Training Applications for Medical Staff 7.4.4.4 Opportunities Potential 7.4.4.4.1 Short-Term 7.4.4.4.2 Mid-Term 7.4.4.4.3 Long-Term 8 Global Hemodynamic Monitoring Devices Market (by Product) 8.1 Opportunity Assessment 8.2 Catheters 8.3 Sensors 8.4 Monitoring System 8.5 Others (Probes, Pods, etc.) 9 Global Hemodynamic Monitoring Devices Market (by Modality) 9.1 Opportunity Assessment 9.2 Invasive 9.3 Minimally Invasive 9.4 Non-Invasive 10 Global Hemodynamic Monitoring Devices Market (by Setting) 10.1 Opportunity Assessment 10.2 Hospitals 10.3 Clinics 10.4 Ambulatory Units 10.5 Homecare 10.6 Others (Nursing Home, Elderly Care Homes, etc.) 11 Global Hemodynamic Monitoring Devices Market (by Geography) 11.1 Overview 11.2 North America Hemodynamic Monitoring Devices Market 11.2.1 Key Findings and Opportunity Assessment 11.2.2 Market Dynamics: Impact Analysis 11.2.3 Market Size and Forecast 11.2.3.1 By Product 11.2.3.2 By Modality 11.2.3.3 By Setting 11.2.3.4 By Country 11.2.3.4.1 U.S. 11.2.3.4.2 Canada 11.3 Europe Hemodynamic Monitoring Devices Market 11.3.1 Key Findings and Opportunity Assessment 11.3.2 Market Dynamics: Impact Analysis 11.3.3 Market Size and Forecast 11.3.3.1 By Product 11.3.3.2 By Modality 11.3.3.3 By Setting 11.3.3.4 By Country 11.3.3.4.1 Germany 11.3.3.4.2 U.K. 11.3.3.4.3 France 11.3.3.4.4 Italy 11.3.3.4.5 Spain 11.3.3.4.6 Nordic Countries 11.3.3.4.7 Rest-of-Europe 11.4 Asia-Pacific Hemodynamic Monitoring Devices Market 11.4.1 Key Findings and Opportunity Assessment 11.4.2 Market Dynamics: Impact Analysis 11.4.3 Market Size and Forecast 11.4.3.1 By Product 11.4.3.2 By Modality 11.4.3.3 By Setting 11.4.3.4 By Country 11.4.3.4.1 Japan 11.4.3.4.2 China 11.4.3.4.3 South Korea 11.4.3.4.4 Australia and New Zealand 11.4.3.4.5 India 11.4.3.4.6 Singapore 11.4.3.4.7 Rest-of-Asia-Pacific 11.5 Latin America Hemodynamic Monitoring Devices Market 11.5.1 Key Findings and Opportunity Assessment 11.5.2 Market Dynamics: Impact Analysis 11.5.3 Market Size and Forecast 11.5.3.1 By Product 11.5.3.2 By Modality 11.5.3.3 By Setting 11.5.3.4 By Country 11.5.3.4.1 Brazil 11.5.3.4.2 Mexico 11.5.3.4.3 Argentina 11.5.3.4.4 Colombia 11.5.3.4.5 Rest-of-Latin America 11.6 Middle East and Africa Hemodynamic Monitoring Devices Market 11.6.1 Key Findings and Opportunity Assessment 11.6.2 Market Dynamics: Impact Analysis 11.6.3 Market Size and Forecast 11.6.3.1 By Product 11.6.3.2 By Modality 11.6.3.3 By Setting 11.6.3.4 By Country 11.6.3.4.1 K.S.A. 11.6.3.4.2 Israel 11.6.3.4.3 South Africa 11.6.3.4.4 Rest-of-MEA 12 Company Profiles 12.1 Overview 12.2 Established Companies 12.2.1 Baxter International Inc. 12.2.1.1 Company Overview 12.2.1.2 Role of Baxter International Inc. in Global Hemodynamic Monitoring Devices Market 12.2.1.3 Key Financials 12.2.1.4 R&D Insights 12.2.1.5 Recent Developments 12.2.1.6 SWOT Analysis 12.2.2 Caretaker, LLC 12.2.2.1 Company Overview 12.2.2.2 Role of Caretaker, LLC in Global Hemodynamic Monitoring Devices Market 12.2.2.3 Recent Developments 12.2.2.4 SWOT Analysis 12.2.3 CN Systems Medizintechnik GmbH 12.2.3.1 Company Overview 12.2.3.2 Role of CN Systems Medizintechnik GmbH in Global Hemodynamic Monitoring Devices Market 12.2.3.3 Recent Developments 12.2.3.4 SWOT Analysis 12.2.4 Deltex Medical Group PLC 12.2.4.1 Company Overview 12.2.4.2 Role of Deltex Medical Group PLC in Global Hemodynamic Monitoring Devices Market 12.2.4.3 Key Financials 12.2.4.4 R&D Insights 12.2.4.5 Recent Developments 12.2.4.6 SWOT Analysis 12.2.5 Drägerwerk AG & Co. KGaA 12.2.5.1 Company Overview 12.2.5.2 Role of Drägerwerk AG & Co. KGaA in Global Hemodynamic Monitoring Devices Market 12.2.5.3 Key Financials 12.2.5.4 R&D Insights 12.2.5.5 Recent Developments 12.2.5.6 SWOT Analysis 12.2.6 Edwards Lifesciences Corporation. 12.2.6.1 Company Overview 12.2.6.2 Role of Edwards Lifesciences Corporation. in Global Hemodynamic Monitoring Devices Market 12.2.6.3 Key Financials 12.2.6.4 R&D Insights 12.2.6.5 Recent Developments 12.2.6.6 SWOT Analysis 12.2.7 GENERAL ELECTRIC COMPANY 12.2.7.1 Company Overview 12.2.7.2 Role of GENERAL ELECTRIC COMPANY in Global Hemodynamic Monitoring Devices Market 12.2.7.3 Key Financials 12.2.7.4 R&D Insights 12.2.7.5 Recent Developments 12.2.7.6 SWOT Analysis 12.2.8 Getinge AB 12.2.8.1 Company Overview 12.2.8.2 Role of Getinge AB in Global Hemodynamic Monitoring Devices Market 12.2.8.3 Key Financials 12.2.8.4 R&D Insights 12.2.8.5 Recent Developments 12.2.8.6 SWOT Analysis 12.2.9 ICU MEDICAL, INC. 12.2.9.1 Company Overview 12.2.9.2 Role of ICU MEDICAL, INC. in Global Hemodynamic Monitoring Devices Market 12.2.9.3 Key Financials 12.2.9.4 R&D Insights 12.2.9.5 Recent Developments 12.2.9.6 SWOT Analysis 12.2.10 Koninklijke Philips N.V. 12.2.10.1 Company Overview 12.2.10.2 Role of Koninklijke Philips N.V. in Global Hemodynamic Monitoring Devices Market 12.2.10.3 Key Financials 12.2.10.4 R&D Insights 12.2.10.5 Recent Developments 12.2.10.6 SWOT Analysis 12.2.11 Masimo Corporation (Parent Company of LiDCO Group PLC) 12.2.11.1 Company Overview 12.2.11.2 Role of Masimo Corporation in Global Hemodynamic Monitoring Devices Market 12.2.11.3 Key Financials 12.2.11.4 R&D Insights 12.2.11.5 Recent Developments 12.2.11.6 SWOT Analysis 12.2.12 NI Medical Ltd. 12.2.12.1 Company Overview 12.2.12.2 Role of NI Medical Ltd. in Global Hemodynamic Monitoring Devices Market 12.2.12.3 Recent Developments 12.2.12.4 SWOT Analysis 12.2.13 Osypka Medical GmbH 12.2.13.1 Company Overview 12.2.13.2 Role of Osypka Medical GmbH in Global Hemodynamic Monitoring Devices Market 12.2.13.3 Recent Developments 12.2.13.4 SWOT Analysis 12.2.14 Schwarzer Cardiotek 12.2.14.1 Company Overview 12.2.14.2 Role of Schwarzer Cardiotek in Global Hemodynamic Monitoring Devices Market 12.2.14.3 Recent Developments 12.2.14.4 SWOT Analysis 12.2.15 Sramek BioDynamics Inc. (Formally Known as Hemo Sapiens Inc.) 12.2.15.1 Company Overview 12.2.15.2 Role of Sramek BioDynamics Inc. in Global Hemodynamic Monitoring Devices Market 12.2.15.3 Recent Developments 12.2.15.4 SWOT Analysis 12.2.16 Uscom Ltd 12.2.16.1 Company Overview 12.2.16.2 Role of Uscom Ltd in Global Hemodynamic Monitoring Devices Market 12.2.16.3 Key Financials 12.2.16.4 R&D Insights 12.2.16.5 Recent Developments 12.2.16.6 SWOT Analysis 12.3 Snapshots of Emerging Companies 12.3.1 Flosonics Medical 12.3.1.1 Company Overview 12.3.1.2 Role of Flosonics Medical in Global Hemodynamic Monitoring Devices Market 12.3.1.3 Recent Developments 12.3.2 Heart Kinetics 12.3.2.1 Company Overview 12.3.2.2 Role of Heart Kinetics in Global Hemodynamic Monitoring Devices Market 12.3.3 Retia Medical 12.3.3.1 Company Overview 12.3.3.2 Role of Retia Medical in Global Hemodynamic Monitoring Devices Market 12.3.3.3 Recent Developments List of Tables Table 1: Global Hemodynamic Monitoring Devices Market, Quarterly Regional Impact, 2020 Table 2: Global Hemodynamic Monitoring Devices Market, Key Technology Trends Table 4.1: Global Hemodynamic Monitoring Devices Market, Quarterly Regional Impact, 2020 Table 5.1: Global Hemodynamic Monitoring Devices Market Funding Scenario, 2017-2021 Table 5.2: European Commission Medical Device Directives Table 5.3: Global Hemodynamic Monitoring Devices Market: Awaited Technologies Table 5.4: Global Hemodynamic Monitoring Devices Market Patent Analysis (by Country), 1985-2021 Table 5.5: Global Hemodynamic Monitoring Devices Product Benchmarking Analysis (by Product Type) Table 5.6: Global Hemodynamic Monitoring Devices Market Ongoing Clinical Trials Table 6.1: Global Hemodynamic Monitoring Devices Market, Business Model Analysis Table 11.1: Prevalence of Cardiovascular Diseases and Diabetes in North America, 2000, 2010, 2018, and 2019 Table 11.2: North America Hemodynamic Monitoring Devices Market, Impact Analysis Table 11.3: Prevalence of Cardiovascular Diseases and Diabetes in Europe, 2000, 2010, 2018, and 2019 Table 11.4: Europe Hemodynamic Monitoring Devices Market, Impact Analysis Table 11.5: Prevalence of Cardiovascular Diseases and Diabetes in Asia-Pacific, 2000, 2010, 2018, and 2019 Table 11.6: Asia-Pacific Hemodynamic Monitoring Devices Market, Impact Analysis Table 11.7: Prevalence of Cardiovascular Diseases and Diabetes in Latin America, 2000, 2010, 2018, and 2019 Table 11.8: Latin America Hemodynamic Monitoring Devices Market, Impact Analysis Table 11.9: Prevalence of Cardiovascular Diseases and Diabetes in Middle East and Africa, 2000, 2010, 2018, and 2019 Table 11.10: Middle East and Africa Hemodynamic Monitoring Devices Market, Impact Analysis List of Figures Figure 1: Global Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 2: Global Hemodynamic Monitoring Devices Market, Impact Analysis Figure 3: Global Hemodynamic Monitoring Devices Market Share Analysis (by Company), 2018-2020 Figure 4: Global Hemodynamic Monitoring Devices Market (by Setting), 2018 and 2030 Figure 5: Global Hemodynamic Monitoring Devices Market (by Region), 2018 and 2030 Figure 2.1: Global Hemodynamic Monitoring Devices Market Segmentation Figure 2.2: Global Hemodynamic Monitoring Devices Market, Regional Segmentation Figure 3.1: Global Hemodynamic Monitoring Devices Market: Research Methodology Figure 3.2: Primary Research Figure 3.3: Secondary Research Figure 3.4: Data Triangulation Figure 3.5: Assumptions and Limitations Figure 4.1: Global Hemodynamic Monitoring Devices Market, Scenario Comparative Analysis Figure 5.1: Global Prevalence (Cardiovascular Diseases), 2000-2030 Figure 5.2: Global Prevalence (Diabetes Mellitus), 2000-2030 Figure 5.3: Global Hemodynamic Monitoring Devices Market: Key Technology Trends Figure 5.4: Global Hemodynamic Monitoring Devices Market Key Trends Short-Term Potential (by Region) Figure 5.5: Global Hemodynamic Monitoring Devices Market Key Trends Mid-Term Potential (by Region) Figure 5.6: Global Hemodynamic Monitoring Devices Market Key Trends Long-Term Potential (by Region) Figure 5.7: Global Hemodynamic Monitoring Devices Market Value Chain Analysis Figure 5.8: Global Hemodynamic Monitoring Devices End User Perceptions Figure 5.9: FDA Regulatory Pathway for Medical Devices Figure 5.10: Health Canada Regulatory Pathway for Device Figure 5.11: MDR Transitional Provisions (EU) Figure 5.12: PMDA Regulatory Pathway for Medical Devices Figure 5.13: NMPA Regulatory Pathway for Medical Device Figure 6.1: Global Hemodynamic Monitoring Devices Market, Share Analysis, (by Company), 2020 Figure 6.2: Global Hemodynamic Monitoring Devices Market, Share of Key Developments and Strategies, January 2016-March 2021 Figure 6.3: Global Hemodynamic Monitoring Devices Market, Regulatory and Legal (by Company), January 2016- March 2021 Figure 6.4: Global Hemodynamic Monitoring Devices Market, Funding Activities (by Company), January 2016- March 2021 Figure 6.5: Global Hemodynamic Monitoring Devices Market, M&A Activities (by Company), January 2016- March 2021 Figure 6.6: Global Hemodynamic Monitoring Devices Market, Partnerships, Collaborations, and Business Expansions (by Company), January 2016- March 2021 Figure 6.7: Global Hemodynamic Monitoring Devices Market, Competitive Benchmarking (by Company) Figure 7.1: Global Hemodynamic Monitoring Devices Market, Realistic Scenario, $Million, 2018-2030 Figure 7.2: Global Hemodynamic Monitoring Devices Market, Pessimistic/ Conservative Growth Scenario, $Million, 2018-2030 Figure 7.3: Global Hemodynamic Monitoring Devices Market, Optimistic Scenario, $Million, 2019-2030 Figure 7.4: Global Hemodynamic Monitoring Devices Market, Impact Analysis Figure 7.5: Rising Prevalence of Cardiac Disorders, 2010-2019 Figure 8.1: Global Hemodynamic Monitoring Devices Market Increment Opportunity (by Product), $Million, 2018 and 2030 Figure 8.2: Global Hemodynamic Monitoring Devices Market (by Catheters), $Million, 2018-2030 Figure 8.3: Global Hemodynamic Monitoring Devices Market (by Sensors), $Million, 2018-2030 Figure 8.4: Global Hemodynamic Monitoring Devices Market (by Monitoring System), $Million, 2018-2030 Figure 8.5: Global Hemodynamic Monitoring Devices Market (by Others), $Million, 2018-2030 Figure 9.1: Global Hemodynamic Monitoring Devices Market Increment Opportunity (by Modality), $Million, 2018 and 2030 Figure 9.2: Global Hemodynamic Monitoring Devices Market (by Invasive), $Million, 2018-2030 Figure 9.3: Global Hemodynamic Monitoring Devices Market (by Minimally Invasive), $Million, 2018-2030 Figure 9.4: Global Hemodynamic Monitoring Devices Market (by Non-Invasive), $Million, 2018-2030 Figure 10.1: Global Hemodynamic Monitoring Devices Market Increment Opportunity (by Setting), $Million, 2018 and 2030 Figure 10.2: Global Hemodynamic Monitoring Devices Market (by Hospitals), $Million, 2018-2030 Figure 10.3: Global Hemodynamic Monitoring Devices Market (by Clinics), $Million, 2018-2030 Figure 10.4: Global Hemodynamic Monitoring Devices Market (by Ambulatory Units), $Million, 2018-2030 Figure 10.5: Global Hemodynamic Monitoring Devices Market (by Homecare), $Million, 2018-2030 Figure 10.6: Global Hemodynamic Monitoring Devices Market (by Others), $Million, 2018-2030 Figure 11.1: Global Hemodynamic Monitoring Devices Market (by Geography), 2018 and 2030 Figure 11.2: Global Hemodynamic Monitoring Devices Market, Increment Opportunity (by Region), $Million, 2018 and 2030 Figure 11.3: North America Hemodynamic Monitoring Devices Market, Incremental Growth Opportunity, $Million, 2018 and 2030 Figure 11.4: North America Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.5: North America Hemodynamic Monitoring Devices Market (by Product), $Million, 2018-2030 Figure 11.6: North America Hemodynamic Monitoring Devices Market (by Modality), $Million, 2018-2030 Figure 11.7: North America Hemodynamic Monitoring Devices Market (by Setting), $Million, 2018-2030 Figure 11.8: North America Hemodynamic Monitoring Devices Market (by Country) Figure 11.9: U.S. Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.10: Canada Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.11: Europe Hemodynamic Monitoring Devices Market, Incremental Growth Opportunity, $Million, 2018 and 2030 Figure 11.12: Europe Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.13: Europe Hemodynamic Monitoring Devices Market (by Product), $Million, 2018-2030 Figure 11.14: Europe Hemodynamic Monitoring Devices Market (by Modality), $Million, 2018-2030 Figure 11.15: Europe Hemodynamic Monitoring Devices Market (by Setting), $Million, 2018-2030 Figure 11.16: Europe Hemodynamic Monitoring Devices Market (by Country) Figure 11.17: Germany Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.18: U.K. Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.19: France Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.20: Italy Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.21: Spain Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.22: Nordic Countries Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.23: Rest-of-Europe Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.24: Asia-Pacific Hemodynamic Monitoring Devices Market, Incremental Growth Opportunity, $Million, 2018 and 2030 Figure 11.25: Asia-Pacific Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.26: Asia-Pacific Hemodynamic Monitoring Devices Market (by Product), $Million, 2018-2030 Figure 11.27: Asia-Pacific Hemodynamic Monitoring Devices Market (by Modality), $Million, 2018-2030 Figure 11.28: Asia-Pacific Hemodynamic Monitoring Devices Market (by Setting), $Million, 2018-2030 Figure 11.29: Asia-Pacific Hemodynamic Monitoring Devices Market (by Country) Figure 11.30: Japan Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.31: China Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.32: South Korea Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.33: Australia and New Zealand Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.34: India Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.35: Singapore Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.36: Rest-of-Asia-Pacific Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.37: Latin America Hemodynamic Monitoring Devices Market, Incremental Growth Opportunity, $Million, 2018 and 2030 Figure 11.38: Latin America Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.39: Latin America Hemodynamic Monitoring Devices Market (by Product), $Million, 2018-2030 Figure 11.40: Latin America Hemodynamic Monitoring Devices Market (by Modality), $Million, 2018-2030 Figure 11.41: Latin America Hemodynamic Monitoring Devices Market (by Setting), $Million, 2018-2030 Figure 11.42: Latin America Hemodynamic Monitoring Devices Market (by Country) Figure 11.43: Brazil Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.44: Mexico Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.45: Argentina Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.46: Colombia Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.47: Rest-of-Latin America Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.48: Middle East and Africa Hemodynamic Monitoring Devices Market, Incremental Growth Opportunity, $Million, 2018 and 2030 Figure 11.49: Middle East and Africa Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.50: Middle East and Africa Hemodynamic Monitoring Devices Market (by Product), $Million, 2018-2030 Figure 11.51: Middle East and Africa Hemodynamic Monitoring Devices Market (by Modality), $Million, 2018-2030 Figure 11.52: Middle East and Africa Hemodynamic Monitoring Devices Market (by Setting), $Million, 2018-2030 Figure 11.53: Middle East and Africa Hemodynamic Monitoring Devices Market (by Country) Figure 11.54: K.S.A. Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.55: Israel Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.56: South Africa Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 11.57: Rest-of-MEA Hemodynamic Monitoring Devices Market, $Million, 2018-2030 Figure 12.1: Shares of Key Companies Profiled Figure 12.2: Baxter International Inc.: Overall Product Portfolio Figure 12.3: Baxter International Inc.: Overall Financials, 2018-2020 Figure 12.4: Baxter International Inc. Revenue (by Business Unit), 2018-2020 Figure 12.5: Baxter International Inc. Revenue (by Region), 2018-2020 Figure 12.6: Baxter International Inc. R&D Expenditure 2018-2020 Figure 12.7: SWOT Analysis: Baxter International Inc. Figure 12.8: Caretaker, LLC: Overall Product Portfolio Figure 12.9: SWOT Analysis: Caretaker, LLC Figure 12.10: CN Systems Medizintechnik GmbH: Overall Product Portfolio Figure 12.11: SWOT Analysis: CN Systems Medizintechnik GmbH Figure 12.12: Deltex Medical Group PLC: Overall Product Portfolio Figure 12.13: Deltex Medical Group PLC.: Overall Financials, 2017-2019 Figure 12.14: Deltex Medical Group PLC Revenue (by Segment), 2017-2019 Figure 12.15: Deltex Medical Group PLC Revenue (by Region), 2017-2019 Figure 12.16: Deltex Medical Group PLC R&D Expenditure 2017-2019 Figure 12.17: SWOT Analysis: Deltex Medical Group PLC Figure 12.18: Drägerwerk AG & Co. KGaA: Overall Product Portfolio Figure 12.19: Drägerwerk AG & Co. KGaA: Overall Financials, 2018-2020 Figure 12.20: Drägerwerk AG & Co. KGaA Revenue (by Region), 2017-2019 Figure 12.21: Drägerwerk AG & Co. KGaA Revenue (by Business Segment), 2020 Figure 12.22: Drägerwerk AG & Co. KGaA R&D Expenditure 2018-2020 Figure 12.23: SWOT Analysis: Drägerwerk AG & Co. KGaA Figure 12.24: Edwards Lifesciences Corporation.: Overall Product Portfolio Figure 12.25: Edwards Lifesciences Corporation.: Overall Financials, 2018-2020 Figure 12.26: Edwards Lifesciences Corporation. Revenue (by Business Segment), 2018-2020 Figure 12.27: Edwards Lifesciences Corporation. Revenue (by Region), 2018-2020 Figure 12.28: Edwards Lifesciences Corporation. R&D Expenditure 2018-2020 Figure 12.29: SWOT Analysis: Edwards Lifesciences Corporation. Figure 12.30: GENERAL ELECTRIC COMPANY.: Overall Product Portfolio Figure 12.31: GENERAL ELECTRIC COMPANY.: Overall Financials, 2018-2020 Figure 12.32: GENERAL ELECTRIC COMPANY Revenue (by Business Segment), 2018-2020 Figure 12.33: GENERAL ELECTRIC COMPANY Revenue (by Region), 2018-2020 Figure 12.34: GENERAL ELECTRIC COMPANY, R&D Expenditure 2018-2020 Figure 12.35: GENERAL ELECTRIC COMPANY, R&D Expenditure Comparison, 2018-2020 Figure 12.36: SWOT Analysis: GENERAL ELECTRIC COMPANY Figure 12.37: Getinge AB: Overall Product Portfolio Figure 12.38: Getinge AB: Overall Financials, 2018-2020 Figure 12.39: Getinge AB Revenue (by Business Segment), 2018-2020 Figure 12.40: Getinge AB Revenue (by Region), 2018-2020 Figure 12.41: Getinge AB R&D Expenditure 2018-2020 Figure 12.42: SWOT Analysis: Getinge AB Figure 12.43: ICU MEDICAL, INC. Overall Product Portfolio Figure 12.44: ICU MEDICAL, INC..: Overall Financials, 2017-2019 Figure 12.45: ICU MEDICAL, INC. Revenue (by Business Unit), 2018-2020 Figure 12.46: ICU MEDICAL, INC. Revenue (by Region), 2018-2020 Figure 12.47: ICU MEDICAL, INC. R&D Expenditure 2017-2019 Figure 12.48: SWOT Analysis: ICU MEDICAL, INC. Figure 12.49: Koninklijke Philip N.V.: Overall Product Portfolio Figure 12.50: Koninklijke Philips N.V.: Overall Financials, 2018-2020 Figure 12.51: Koninklijke Philips N.V. Revenue (by Business Segment), 2018-2020 Figure 12.52: Koninklijke Philips N.V. Revenue (by Region), 2018-2020 Figure 12.53: Koninklijke Philips N.V. R&D Expenditure 2018-2020 Figure 12.54: SWOT Analysis: Koninklijke Philips N.V. Figure 12.55: Masimo Corporation: Overall Product Portfolio Figure 12.56: LiDCO Group PLC.: Overall Financials, 2018-2020 Figure 12.57: LiDCO Group PLC Revenue (by Region), 2018-2020 Figure 12.58: LiDCO Group PLC R&D Expenditure 2018-2020 Figure 12.59: SWOT Analysis: Masimo Corporation (Parent Company of LiDCO Group PLC) Figure 12.60: NI Medical Ltd.: Overall Product Portfolio Figure 12.61: SWOT Analysis: NI Medical Ltd. Figure 12.62: Osypka Medical GmbH: Overall Product Portfolio Figure 12.63: SWOT Analysis: Osypka Medical GmbH Figure 12.64: Schwarzer Cardiotek: Overall Product Portfolio Figure 12.65: SWOT Analysis: Schwarzer Cardiotek Figure 12.66: Sramek BioDynamics Inc.: Overall Product Portfolio Figure 12.67: SWOT Analysis: Sramek BioDynamics Inc. Figure 12.68: Uscom Ltd: Overall Product Portfolio Figure 12.69: Uscom Ltd.: Overall Financials, 2018-2020 Figure 12.70: Uscom Ltd Revenue (by Product), 2018-2020 Figure 12.71: Uscom Ltd Revenue (by Region), 2018-2020 Figure 12.72: Uscom Ltd R&D Expenditure 2018-2020 Figure 12.73: SWOT Analysis: Uscom Ltd